Research Management Group (RMG)

The Samuel Waxman Cancer Research Foundation
Reprogramming the Cancer Cell

***Limited submission funding opportunity-only one application is permitted from the instituton. An internal selection process required***

This webpage contains the internal selection process for 2013 and is for your reference only.  It was not offered in 2014.

Program guidelines:    Download PDF file PDF file
These guidelines are not available on the sponsor's website. provided for your reference only. Please see the internal submission guidelines below.

# of applicants permitted: 1 (see Internal Selection process-Submission Guidelines below)

Timeline:
Internal Cancer Institute deadline: Jan. 28, 2013, 4 p.m. (see internal submission guidelines below)
February 11, 2013--date final applicant selected by the Cancer Institute internal review committee will be notified to proceed with the full application
March 11, 2013--date the final applicant must submit his/her full application to his/her Research Process Manager (RPM) in RMG
March 18, 2013--date final application due at the Samuel Waxman Cancer Research Foundation


Eligibility

Amount of funding:
An initial, two-year grant will consist of up to $100,000 per year of direct cost (no indirects). Upon completion of two years of funding (assuming satisfactory progress made in each year based on the Scientific Advisory Committee review), review of progress and approval by the grants review committee, a third year of funding may be considered.

Purpose
The Samuel Waxman Cancer Research Foundation (SWCRF), founded in 1976, is a non-profit organization dedicated to conducting basic and translational cancer research. Investigators of the Foundation have long been interested in differentiation therapy of cancer- the notion that the cancer cell can be re-programmed to re-acquire aspects of normal cell differentiation including terminal cell division and programmed cell death. In 2013, the Foundation will offer several grants of up to $100,000 per year to fund novel research along these lines.


Research Themes

1. Basic and translational research focused on mechanisms of gene regulation that govern critical cell decisions in the process of cell diversification from the tumor initiating cell to the differentiated state

2. Projects on aberrant gene regulators in malignancy

3. Research on aberrant epigenetics in malignancy

4. Studies on the cell decisions on cell dormancy versus proliferation

5. Research on cell life and death


Priority will be given to:

 

Internal Selection Process-Submission Guidelines

By Jan. 28, 2013, 4 p.m., please send one PDF file containing a two-page proposal and curriculum vitae to:

Denise Baughman
Project Manager at the Cancer Institute
deniseb@stanford.edu

Selection Process
The internal proposals will be distributed to the Cancer Institute Internal Review Committee, which will select the applicant to represent the Stanford Cancer Institute.

 

Contact Person/Questions:
Denise Baughman
Project Manager, Cancer Institute
265 Campus Drive, G2103
t 650-724-9547
deniseb@stanford.edu

 


Stanford Medicine Resources:

Footer Links: